Escitalopram Actavis

Leaflet accompanying the packaging: information for the user

Warning! The leaflet should be kept. Information on the immediate packaging in a foreign language.

Escitalopram Actavis,20 mg, coated tablets
Escitalopramum

You should carefully read the contents of the leaflet before taking the medicine, as it contains important information for the patient.

• You should keep this leaflet, so that you can read it again if you need to.
• If you have any doubts, you should consult a doctor or pharmacist.
• This medicine has been prescribed to you specifically. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same as yours.
• If the patient experiences any side effects, including any not listed in the leaflet, they should tell their doctor, pharmacist, or nurse. See section 4.

Table of contents of the leaflet

• 1. What is Escitalopram Actavis and what is it used for
• 2. Important information before taking Escitalopram Actavis
• 3. How to take Escitalopram Actavis
• 4. Possible side effects
• 5. How to store Escitalopram Actavis
• 6. Contents of the packaging and other information

1. What is Escitalopram Actavis and what is it used for

Escitalopram Actavis contains the active substance escitalopram. Escitalopram Actavis belongs to a group of antidepressant medicines called selective serotonin reuptake inhibitors (SSRIs). These medicines work on the serotonin system in the brain by increasing the level of serotonin. Disturbances in the serotonin system in the brain are believed to play a key role in the development of depression and related disorders.
Escitalopram Actavis is used to treat depression (major depressive episodes), anxiety disorders (such as panic disorder with or without agoraphobia, social anxiety disorder, generalized anxiety disorder, and obsessive-compulsive disorder).
It may take a few weeks before you start to feel better. You should continue to take Escitalopram Actavis even if it takes some time before you feel any improvement. If you do not feel better or feel worse, you should consult your doctor.

2. Important information before taking Escitalopram Actavis

When not to take Escitalopram Actavis

• if you are allergic to escitalopram or any of the other ingredients of this medicine (listed in section 6);
• if you are taking medicines that belong to a group called MAOIs (including selegiline, used to treat Parkinson's disease, moclobemide, used to treat depression, and linezolid, an antibiotic);
• if you have been born with a heart rhythm disorder or have had an episode of irregular heart rhythm (visible on an ECG, a test that checks how your heart works);
• if you are taking medicines that affect heart rhythm or medicines that may affect heart rhythm (see section 2 "Escitalopram Actavis and other medicines").

Warnings and precautions

Before taking Escitalopram Actavis, you should consult your doctor or pharmacist.
You should tell your doctor if you have any other conditions or diseases, as your doctor should take this information into account. In particular, you should inform your doctor:

• if you have epilepsy. Treatment with Escitalopram Actavis should be discontinued if seizures occur for the first time or if their frequency increases (see also section 4 "Possible side effects");
• if you have liver or kidney function disorders. A dose adjustment by your doctor may be required;
• if you have diabetes. Treatment with Escitalopram Actavis may affect blood sugar control. A dose adjustment of insulin and/or oral hypoglycemic agents may be required;
• if you have low sodium levels in your blood;
• if you have an increased tendency to bleed or bruise or if you are pregnant (see "Pregnancy, breastfeeding, and fertility");
• if you are being treated with electroconvulsive therapy;
• if you have coronary heart disease;
• if you have or have had heart problems or have recently had a heart attack;
• if you have low resting heart rate and/or know that you have a lack of salts due to prolonged, severe diarrhea and vomiting or the use of diuretic medicines;
• if you experience rapid or irregular heartbeat, fainting, collapse, or dizziness when changing position to standing, which may indicate abnormal heart function;
• if you have or have had eye problems, such as certain types of glaucoma (increased pressure inside the eyeball).

Warning

In some patients with bipolar affective disorder, a manic phase may occur. This is characterized by unusual and rapidly changing ideas, unjustified feelings of happiness, and excessive physical activity. If these symptoms occur, you should consult your doctor.
In the first few weeks of treatment, symptoms such as anxiety or difficulty sitting or standing still may also occur. If such symptoms appear, you should immediately inform your doctor.
Medicines like Escitalopram Actavis (so-called SSRIs or SNRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms have persisted after discontinuation of treatment.

Suicidal thoughts and worsening of depression or anxiety disorder

In cases of depression and/or anxiety disorders, suicidal thoughts or self-harm thoughts may also occur. Such symptoms or behavior may worsen at the start of treatment with antidepressant medicines, as these medicines usually start working only after about 2 weeks, sometimes later.
The likelihood of such thoughts occurring is higher if:

• the patient has had suicidal thoughts or self-harm thoughts before,
• the patient is an adult in young age. Information from clinical trials has shown an increased risk of suicidal behavior in adults under 25 years of age with mental disorders treated with antidepressant medicines. If suicidal thoughts or self-harm thoughts occur, you should contact your doctor or go to the hospital immediately.

It may be helpful to inform your family or friendsabout your depression or anxiety disorder and ask them to read this leaflet. You may ask them to tell you if they notice that your depression or anxiety is getting worse or if you are experiencing worrying changes in your behavior.

Children and adolescents

Escitalopram Actavis should not be used in children and adolescents under 18 years of age.
It should also be noted that in the case of taking medicines from this group, patients under 18 years of age are at increased risk of side effects, such as suicidal attempts, suicidal thoughts, and hostility (especially aggression, rebellious behavior, and expressions of anger). Nevertheless, your doctor may prescribe Escitalopram Actavis to patients under 18 years of age, considering that it is in their best interest. If you have been prescribed Escitalopram Actavis and have any doubts, you should consult your doctor again. If any of the above symptoms occur in a patient under 18 years of age taking Escitalopram Actavis, you should inform your doctor. Additionally, the long-term safety of Escitalopram Actavis regarding growth, maturation, and cognitive development in this age group has not been established yet.

Escitalopram Actavis and other medicines

You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
You should inform your doctor if you are taking any of the following medicines:

• non-selective monoamine oxidase inhibitors (MAOIs) containing substances such as phenelzine, iproniazid, isocarboxazid, nialamide, and tranylcypromine. If you have taken any of these medicines, you should wait 14 days before starting to take Escitalopram Actavis. After stopping treatment with Escitalopram Actavis, you should wait 7 days before taking any of these medicines;
• reversible, selective monoamine oxidase A (MAO-A) inhibitors containing moclobemide (used to treat depression);
• irreversible monoamine oxidase B (MAO-B) inhibitors containing selegiline (used to treat Parkinson's disease). These medicines increase the risk of side effects;
• the antibiotic linezolid;
• lithium (used to treat bipolar affective disorder) and tryptophan;
• imipramine and desipramine (used to treat depression);
• sumatriptan and similar medicines (used to treat migraine), tramadol, and buprenorphine (used to treat severe pain). These medicines may increase the risk of side effects;
• cimetidine, lansoprazole, omeprazole, and esomeprazole (used to treat stomach ulcers), fluconazole (an antifungal medicine), fluvoxamine (an antidepressant), and ticlopidine (used to reduce the risk of stroke). These medicines may cause an increase in escitalopram levels in the blood;
• St. John's wort (Hypericum perforatum), a herbal medicine used to treat depression;
• acetylsalicylic acid and non-steroidal anti-inflammatory drugs (used as painkillers or to thin the blood, known as anticoagulants). They may increase the risk of bleeding;
• warfarin, dipyridamole, and phenprocoumon (used to thin the blood, known as anticoagulants). Your doctor may order a blood test to check the blood clotting time at the start and after stopping treatment with Escitalopram Actavis to determine if the dose of the anticoagulant is still appropriate;
• mefloquine (used to treat malaria), bupropion (used to treat depression), and tramadol (used to treat severe pain) due to the possible risk of lowering the seizure threshold;
• neuroleptics (used to treat schizophrenia, psychosis) and antidepressants (tricyclic antidepressants and SSRIs) due to the possible risk of lowering the seizure threshold;
• flecainide, propafenone, and metoprolol (used to treat heart conditions), desipramine, clomipramine, and nortriptyline (antidepressants), and risperidone, thioridazine, and

haloperidol (antipsychotic medicines). A dose adjustment of Escitalopram Actavis may be required;

• medicines that lower potassium or magnesium levels in the blood, as they increase the risk of life-threatening heart rhythm disorders.

DO NOT TAKE Escitalopram Actavisif you are taking medicines used to treat heart conditions or medicines that may affect heart rhythm, such as:

• anti-arrhythmic medicines of class IA and III, antipsychotic medicines (e.g., phenothiazine derivatives, pimozide, haloperidol), tricyclic antidepressants, and some antibacterial medicines (e.g., sparfloxacin, moxifloxacin, intravenous erythromycin, pentamidine, antimalarial medicines, especially halofantrine),
• certain antihistamines (astemizole, hydroxyzine, mizolastine).

If you have any doubts about taking the medicine, you should consult your doctor.

Escitalopram Actavis with food, drink, or alcohol

Escitalopram Actavis can be taken with or without food (see section 3 "How to take Escitalopram Actavis").
As with many medicines, it is not recommended to take Escitalopram Actavis and alcohol at the same time, although interactions between Escitalopram Actavis and alcohol are not expected.

Pregnancy, breastfeeding, and fertility

If you are pregnant, breastfeeding, or think you may be pregnant, you should consult your doctor or pharmacist before taking this medicine.
You should not take Escitalopram Actavis during pregnancy and breastfeeding, unless you have discussed the risks and benefits with your doctor.
If you take Escitalopram Actavis during the last 3 months of pregnancy, you should be aware that your newborn baby may experience the following symptoms: difficulty breathing, blue skin, seizures, changes in body temperature, difficulty feeding, vomiting, low blood sugar, stiffness or floppiness, increased reflexes, tremors, nervousness, irritability, lethargy, crying, sleepiness, and difficulty sleeping. If your newborn baby experiences any of these symptoms, you should contact your doctor immediately.
You should inform your doctor and/or midwife that you are taking Escitalopram Actavis. Taking medicines like Escitalopram Actavis, especially in the last 3 months of pregnancy, may increase the risk of a serious condition in the newborn called persistent pulmonary hypertension of the newborn (PPHN). This condition is characterized by rapid breathing and blue skin, and usually occurs in the first day after birth. If such symptoms occur in your newborn baby, you should contact your doctor and/or midwife immediately.
You should not stop taking Escitalopram Actavis during pregnancy.
Taking Escitalopram Actavis at the end of pregnancy may increase the risk of severe bleeding from the vagina, occurring shortly after delivery, especially if you have a history of bleeding disorders. If you are taking Escitalopram Actavis, you should inform your doctor or midwife so that they can give you appropriate advice.
It is assumed that escitalopram passes into breast milk.
In animal studies, it has been shown that citalopram, a medicine similar to escitalopram, affects sperm quality. This may theoretically affect fertility, but no effect on fertility has been observed in humans yet.

Driving and using machines

You should not drive or operate machinery until you know how Escitalopram Actavis affects you.

Escitalopram Actavis contains sodium

This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially "sodium-free".

3. How to take Escitalopram Actavis

This medicine should always be taken as directed by your doctor. If you are unsure, you should consult your doctor or pharmacist.
The following doses of Escitalopram Actavis are available: 10 mg, 15 mg, and 20 mg.
Adults
Depression
The recommended dose of Escitalopram Actavis is 10 mg and is taken as one dose per day. The dose may be increased by your doctor to a maximum of 20 mg per day.
Panic disorder with agoraphobia
The initial dose of Escitalopram Actavis is 5 mg per day for the first week of treatment, then the dose is increased to 10 mg per day. The dose may then be increased by your doctor to a maximum of 20 mg per day.
Social anxiety disorder
The recommended dose of Escitalopram Actavis is 10 mg and is taken as one dose per day. The dose may then be decreased by your doctor to 5 mg per day or increased to a maximum of 20 mg per day, depending on your response to the medicine.
Generalized anxiety disorder
The recommended dose of Escitalopram Actavis is 10 mg and is taken as one dose per day. The dose may be increased by your doctor to a maximum of 20 mg per day.
Obsessive-compulsive disorder
The recommended dose of Escitalopram Actavis is 10 mg and is taken as one dose per day. The dose may be increased by your doctor to a maximum of 20 mg per day.
Elderly patients (over 65 years)
The recommended initial dose of Escitalopram Actavis is 5 mg and is taken as one dose per day. The dose may be increased by your doctor to 10 mg per day.
Use in children and adolescents
Escitalopram Actavis should not normally be used in children and adolescents. For further information, see section 2 "Important information before taking Escitalopram Actavis".
Renal impairment
Caution should be exercised in patients with severe renal impairment. The medicine should be taken as directed by your doctor.
Hepatic impairment
Patients with hepatic impairment should not exceed a dose of 10 mg per day. The medicine should be taken as directed by your doctor.
Poor metabolizers of medicines via the CYP2C19 enzyme
Patients with this known genotype should not exceed a dose of 10 mg per day. The medicine should be taken as directed by your doctor.
The coated tablets should be taken once a day, swallowed whole with sufficient liquid (preferably a glass of water). Escitalopram Actavis can be taken with or without food.
If necessary, the tablet can be divided into two equal doses by placing it on a flat surface with the score line facing up. The tablet can then be broken into two equal doses by pressing down on each end with your index fingers, as shown in the picture.

Duration of treatment
You may not feel better until after a few weeks of treatment. You should therefore continue to take Escitalopram Actavis even if it takes some time before you feel any improvement. You should not change the dose without consulting your doctor.
Escitalopram Actavis should be taken for as long as your doctor recommends. If you stop treatment too early, your symptoms may return. It is recommended to continue treatment for at least 6 months after you have felt better.

Taking a higher dose of Escitalopram Actavis than recommended

If you have taken a higher dose of Escitalopram Actavis than prescribed, you should contact your doctor or go to the emergency room immediately. You should do this even if you do not feel any discomfort.
Symptoms of overdose include dizziness, tremors, agitation, coma, nausea, vomiting, heart rhythm disturbances, low blood pressure, and electrolyte disturbances. You should take the packaging of Escitalopram Actavis with you to the doctor or hospital.

Missing a dose of Escitalopram Actavis

You should not take a double dose to make up for a missed dose. If you have missed a dose and remember before bedtime, you should take the missed dose immediately. You should take the next dose the following day. If you remember that you have missed a dose in the night or the next day, you should skip the missed dose and take the next dose as usual.

Stopping treatment with Escitalopram Actavis

You should not stop taking Escitalopram Actavis unless your doctor tells you to. When you stop treatment, it is usually recommended to gradually reduce the dose of Escitalopram Actavis over a period of several weeks.
After stopping treatment with Escitalopram Actavis, especially if it is stopped abruptly, you may experience withdrawal symptoms. These symptoms are common after stopping treatment with Escitalopram Actavis. The risk is higher if Escitalopram Actavis has been taken for a long time, in high doses, or if the dose has been reduced too quickly. In most patients, the symptoms are mild and disappear on their own within two weeks. In some patients, however, they may be more severe or persist for longer (more than 2-3 months). If you experience severe withdrawal symptoms, you should contact your doctor. Your doctor may recommend restarting treatment with Escitalopram Actavis and tapering it off more slowly.
Withdrawal symptoms include dizziness (unsteady gait, balance disturbances), tingling sensation, burning sensation, and (less commonly) electric shock sensations, also in the head, sleep disturbances (vivid dreams, nightmares, insomnia), anxiety, headache, nausea and/or vomiting, sweating (including night sweats), restlessness or agitation, tremors, disorientation, emotional instability or irritability, diarrhea, visual disturbances, or palpitations (heart palpitations).
If you have any further doubts about taking the medicine, you should consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects usually disappear after a few weeks of treatment. You should remember that some of these side effects may also be symptoms of your illness, and they will disappear as you get better.

If you experience any of the following side effects during treatment, you should contact your doctor or go to the hospital immediately:

Uncommon(may affect up to 1 in 100 people):

• unusual bleeding, including gastrointestinal bleeding.

Rare(may affect up to 1 in 1,000 people):

• swelling of the skin, tongue, lips, throat, or face, hives, or difficulty breathing or swallowing (severe allergic reaction)
• high fever, agitation, confusion (disorientation), tremors, and sudden muscle contractions, which can be symptoms of a rare disorder called serotonin syndrome.

Frequency not known(frequency cannot be estimated from the available data)

• difficulty urinating
• seizures, see also section "Warnings and precautions"
• yellowing of the skin and whites of the eyes, which can be a sign of liver dysfunction/liver inflammation
• rapid or irregular heartbeat, fainting, which can be symptoms of a life-threatening condition called Torsades de Pointes
• suicidal thoughts and behaviors, see also section "Warnings and precautions"
• sudden swelling of the skin or mucous membranes (angioedema)

The following side effects have also been reported:

Very common(may affect more than 1 in 10 people):

• nausea
• headache

Common(may affect up to 1 in 10 people):

• nasal congestion or sinusitis (sinus infection)
• decreased or increased appetite
• anxiety, restlessness, unusual dreams, difficulty sleeping, sleepiness, dizziness, yawning, tremors, tingling sensation
• diarrhea, constipation, vomiting, dry mouth
• increased sweating
• muscle and joint pain
• sexual dysfunction (delayed ejaculation, erectile dysfunction, decreased libido, and possible difficulty achieving orgasm in women)
• fatigue, fever
• weight gain

Uncommon(may affect up to 1 in 100 people):

• hives, rash, itching
• grinding of the teeth, agitation, nervousness, panic attacks, confusion (disorientation)
• sleep disturbances, taste disturbances, fainting (syncope)
• dilated pupils, vision disturbances, ringing in the ears (tinnitus)
• hair loss
• heavy menstrual bleeding
• irregular menstrual periods
• weight loss
• rapid heartbeat
• swelling of the arms or legs
• nosebleeds

Rare(may affect up to 1 in 1,000 people):

• aggression, depersonalization (feeling of loss of one's own identity, feeling of not being oneself), hallucinations
• slow heartbeat

Frequency not known(frequency cannot be estimated from the available data):

• decreased sodium levels in the blood (symptoms include nausea and malaise with muscle weakness or confusion)
• dizziness when standing up due to low blood pressure (orthostatic hypotension)
• abnormal liver function test results (increased liver enzyme activity in the blood)
• movement disorders (involuntary muscle movements)
• painful erection of the penis (priapism)
• symptoms of unusual bleeding in the skin and mucous membranes (ecchymoses)
• low platelet count (thrombocytopenia)
• increased secretion of antidiuretic hormone (ADH), leading to water retention in the body, dilutional hyponatremia, and decreased sodium levels
• galactorrhea (milk secretion) in men and women who are not breastfeeding
• severe postpartum hemorrhage (postpartum hemorrhage), see additional information in subsection "Pregnancy, breastfeeding, and fertility" in section 2
• mania
• patients taking medicines from this group have been observed to have an increased risk of fractures
• changes in heart rhythm (called "QT interval prolongation", visible on an ECG, a test that evaluates heart function)

The following side effects have also been reported for medicines with a similar mechanism of action to escitalopram (the active substance of Escitalopram Actavis):

• restlessness (akathisia)
• loss of appetite

Reporting side effects

If you experience any side effects, including any not listed in the leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety, Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych, Al. Jerozolimskie 181C, 02-222 Warszawa, tel.: + 48 22 49 21 301, fax: + 48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Escitalopram Actavis

The medicine should be stored out of sight and reach of children.
You should not take this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Do not store above 25°C.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Escitalopram Actavis contains

The active substance of Escitalopram Actavis is escitalopram. Each coated tablet contains 20 mg of escitalopram (as escitalopram oxalate).
Other ingredients of the medicine are:
Tablet core: microcrystalline cellulose, anhydrous colloidal silica, sodium croscarmellose, talc, magnesium stearate;
Tablet coating: hypromellose 6cP, titanium dioxide (E 171), macrogol 6000.

What Escitalopram Actavis looks like and contents of the pack

Oval, biconvex, white coated tablets (8 mm x 11.7 mm) with a score line on one side and notches on the sides, marked with "E" on the other side. The tablet can be divided into equal doses.
Escitalopram Actavis is available in blister packs of 28 coated tablets in a cardboard box.
For more detailed information, you should consult the marketing authorization holder or parallel importer.

Marketing authorization holder in Lithuania, the country of export:

Teva B.V.
Swensweg 5
2031 GA Haarlem
Netherlands

Manufacturer:

Actavis Ltd
BLB 015-016 Bulebel Industrial Estate
Zejtun ZTN 3000, Malta

Parallel importer:

Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź

Repackaged by:

Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Lithuanian, export country marketing authorization number: LT/1/09/1815/038

Parallel import authorization number: 382/24

Leaflet approval date: 31.10.2024

[Information about the trademark]